Published: 14 September 2021
Views:
432
Likes:
0
Overview
Full programme
In diesem Peer-to-Peer-Video zu den kommenden Herzinsuffizienz-Leitlinien geben uns Prof. Böhm, Prof. Hassenfuß und Prof. Anker eine lokale Interpretation. Zunächst werfen wir einen Blick auf die Richtlinien von 2016 und betrachten dann die Anpassungen der ESC-Herzinsuffizienz-Leitlinien von 2021 und was diese für die Verwendung von SGLT-2-Inhibitoren bei HFrEF bedeuten. Insbesondere betrachten wir die Entwicklung der neuen Leitlinien näher und überlegen, wie diese in der zukünftigen Praxisarbeit umgesetzt werden sollten.
Videofilmer: Mike Knight
Editor: Oliver Miles
Part 1
1 session
Sitzung 1: Woher kommen wir?
Watch nowPart 2
1 session
Sitzung 2: Update zu den Empfehlungen der ESC-HF-Leitlinie 2021 für SGLT-2-Inhibitoren
Watch nowPart 3
1 session
Sitzung 3: Untersuchung der klinischen Daten hinter Leitlinienaktualisierungen
Watch nowPart 4
1 session
Sitzung 4: Praxis mit SGLT-2-Hemmern
Watch now
Gerd Hasenfuss
Dr Gerd Hasenfuss is a Professor of Internal Medicine, Director of the Department of Cardiology and Pulmonology, Georg-August-Universität Göttingen; Chairman of the Heart Center and the Herzforschungszentrum Göttingen; Head of Internal Medicine, Clinic and Rehabilitation Center Lippoldsberg gGmbH.
Michael Böhm
Dr Michael Böhm performed his medical training at the Medical School of Hannover in Germany. Residency in Internal Medicine and fellowships in Cardiology at the Ludwig Maximilians-Unversity in Munich/Germany at the Klinikum Großhadern; Heisenberg Graduate of the Deutsche Forschungsgemeinschaft; Assistant and Associate Dr of Internal Medicine and Cardiology at the Universität zu Köln in Germany.
Dr Böhm is Director of the Klinik für Innere Medizin III and Chief of Cardiology at the University of the Saarland in Homburg/Saar in Germany. Dr Böhm's special interest includes pathophysiology and therapy of heart failure. Particular, he is involved in studies on signal transduction in the failing heart and in vascular biology. Dr Böhm has been the principal investigator in several international multicenter studies. He has written more than 350 original papers, book chapters and review articles. He has obtained several awards of scientific societies. Dr Böhm is a reviewer for most…
Stefan Anker
Dr Stefan Anker was born in East Berlin, Germany in 1965 and has been a doctor for almost thirty years. In his own words, he “never considered doing anything other than medicine.” He is a prodigious researcher who has published over 950 original papers, reviews and editorials.
Dr Anker has also won a number of awards, including the 2018 Copernicus Prize from the German DFG and Polish FNP. Working with both systems in the United Kingdom and Germany has been enjoyable for him because he loves the freedom that it provides as an academic. He would like to play more tennis or golf if he had the time, and enjoys collecting sculptures; particularly anything “skinny or thin.”
Dr Anker studied medicine at Charité Medical School of Humboldt-University Berlin, Germany from 1987 to 1993. He went on to complete his PhD at the N
